Roman Butler Fullerton & Co. Purchases Shares of 7,143 National Health Investors, Inc. $NHI

Roman Butler Fullerton & Co. acquired a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,143 shares of the real estate investment trust’s stock, valued at approximately $542,000.

A number of other hedge funds have also modified their holdings of the stock. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors during the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC increased its stake in National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in National Health Investors during the fourth quarter valued at about $33,000. Advisory Services Network LLC purchased a new stake in National Health Investors during the third quarter valued at about $65,000. Finally, Triumph Capital Management acquired a new position in shares of National Health Investors in the third quarter worth about $66,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Stock Down 0.1%

NHI stock opened at $72.91 on Monday. The company has a 50 day moving average of $75.28 and a two-hundred day moving average of $79.32. The company has a market cap of $3.58 billion, a price-to-earnings ratio of 21.07, a PEG ratio of 3.34 and a beta of 0.51. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business had revenue of $121.32 million for the quarter. During the same quarter in the prior year, the firm earned $1.22 earnings per share. The company’s revenue was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts anticipate that National Health Investors, Inc. will post 4.77 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.0%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s payout ratio is currently 106.36%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Truist Financial dropped their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Wells Fargo & Company reduced their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

Insider Activity

In other news, CEO D. Eric Mendelsohn purchased 1,500 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average price of $68.84 per share, with a total value of $103,260.00. Following the purchase, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This represents a 1.14% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 2.70% of the stock is owned by insiders.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.